// App-Quantinova.ai

e14632 : Hepatic artery infusion for recurrent or chemoresistant hepatic malignancy.

Researchers

Presenter

  • Harold J. Wanebo

Principal Investigators

  • Charu Taneja

  • Riogard Srinivasa

  • Giovanni Begossi

  • James Belliveau

Medical Centers

  • Landmark Medical Center, Woonsocket, RI

  • Hurley Medical Center, Flint, MIRoswell Park Cancer Institute, Buffalo, NYRhode Island Hospital, Providence, RI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Intestinal carcinoid tumor

Biomarkers

  • Carcinoembryonic antigen

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Capecitabine

  • Oxaliplatin

  • Doxorubicin

  • Irinotecan

  • Cisplatin

Outcome

  • Positive


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final